Professor Mimi Tang named ASEAN-Australia Centre Advisory Board Chair

Published

Monday, February 17, 2025 - 9:00 AM

Professor Mimi Tang, NACE Food Allergy Stream Advisory Group member, has been appointed as inaugural Chair of the ASEAN-Australia Centre Advisory Board.

The ASEAN-Australia Centre, a Federal Government initiative that supports the South East Asia Economic Strategy to 2040, will deepen economic and diplomatic ties between Australia and Southeast Asia.

The Centre’s programs support emerging leaders and young female entrepreneurs and will create a First Nations digital art exhibition in Southeast Asia. It will also bolster partnerships that connect Australian and Southeast Asian students and teachers.

Federal Foreign Affairs Penny Wong made the announcement of Professor Tang’s new position. Professor Tang is Murdoch Children's Research Institute (MCRI) head of Allergy Immunology and Centre for Food Allergy Research (CFAR) Chief Investigator. She is a leading allergy researcher and has pioneered an oral immunotherapy treatment (OIT) for peanut allergy that was found to induce remission in many children including Stella.

Professor Tang is also a Consultant Immunologist Allergist at The Royal Children’s Hospital and the CEO and scientific founder of Prota Therapeutics, a biotech startup focussed on developing OIT for food allergies.

Her ties to Southeast Asia are strong, with Professor Tang born in Singapore and growing up in Malaysia before moving to Australia in primary school.

Professor Tang said she was excited to make an impact at the ASEAN-Australia Centre.

“It’s an honour to elevate the work of Southeast Asian women and turbocharge various business and creative ventures that will benefit both our regions,” she said.

“This is a fantastic opportunity and I am proud to strengthen the connection between Australia and a dynamic, diverse area that I have a strong personal connection with.”

This article first appeared on Murdoch Children's Research Institute